Indo Borax Q4 FY26 Results: Revenue Up 25.7%, PAT Rises 41.9%
Indo Borax & Chemicals reported Q4 FY26 revenue of ₹63.01 Cr (up 25.7% YoY) and PAT of ₹14.53 Cr (up 41.9% YoY). For FY26, revenue was ₹215.45 Cr, and PAT was ₹50.27 Cr. The company announced a ₹10 final dividend and a ₹30 special dividend. A 50.80% promoter stake was transferred in January 2026.
The announcement includes significant financial performance improvements, a substantial dividend payout, and a major ownership transition involving over 50% of the company's stake. These factors are likely to have a considerable impact on investor perception and the company's future strategic direction.
The company reported strong year-on-year growth in revenue and profit for both the quarter and the full fiscal year. The announcement of substantial dividends and the near-zero debt position further contribute to a positive sentiment. The mention of future growth opportunities and strategic initiatives also adds to the positive outlook.
Indo Borax & Chemicals Limited has announced its financial results for the quarter and year ended March 31, 2026. The company reported a consolidated operating revenue of ₹63.01 crore for Q4 FY26, marking a year-on-year increase of 25.7%. EBITDA for the quarter rose by 25.7% to ₹12.82 crore, with a maintained margin of 20.4%. Net profit saw a significant jump of 41.9% to ₹14.53 crore, resulting in an Earnings Per Share (EPS) of ₹4.53.
For the full fiscal year FY26, consolidated operating revenue grew by 22.9% to ₹215.45 crore. Profit After Tax (PAT) increased by 18.3% to ₹50.27 crore, and EPS stood at ₹15.67. The company maintained healthy profitability with an EBITDA margin of 20.5% and a PAT margin of 21.8% for FY26. The Board has announced a final dividend of ₹10 per share and a special dividend of ₹30 per share for FY26, reflecting robust liquidity and a near-zero debt position.
The company's investor presentation highlights its leading position in the Indian Boric Acid market with a market share of approximately 50% and a production capacity of 20,000 MTPA, along with a 6,000 MTPA capacity for Disodium Octaborate Tetrahydrate (DOT). The presentation also details a significant ownership transition where the promoter group agreed to sell an aggregate of 1,63,00,230 equity shares, representing approximately 50.80% of the total paid-up equity share capital, to Zenrock Chemicals Private Limited and investment funds India Special Assets Fund III, ISAF III Onshore Fund, and Special Situation India Fund. The stake transfer was completed on January 23, 2026.
Management commentary from Mr. Suresh Kalra, Managing Director & CEO, expressed optimism about future growth, driven by initiatives like 'Aatmanirbhar Bharat' and 'Make in India', and highlighted the company's strong financial performance, operational efficiencies, and strategic expansion. The company is evaluating downstream expansion and debottlenecking opportunities to capture incremental domestic demand for Boric Acid, which is projected to grow at a CAGR of 7%-8% from FY26 to FY30.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.